Mathew L. Thakur,Kaijun Zhang,Bishnuhari Paudyal,Devadhas Devakumar,Maria Y. Covarrubias,Chang-po Chen,Brian D. Gray,Eric Wickstrom,Koon Y. Pak

Abstract:Erratum to: Targeting Apoptosis for Optical Imaging of Infection Mathew L. Thakur, Kaijun Zhang, Bishnuhari Paudyal, Devadhas Devakumar, Maria Y. Covarrubias, Chang-po Chen, Brian D. Gray, Eric Wickstrom, Koon Y. Pak Department of Radiology, Thomas Jefferson University, 1020 Locust Street, Suite 359-JAH, Philadelphia, PA 19107, USA Department of Biochemistry Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA Bioimaging, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Molecular Targeting Technologies, Inc., West Chester, PA, USA

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum

Excretable IR-820 for in vivo NIR-II fluorescence cerebrovascular imaging and photothermal therapy of subcutaneous tumor: Erratum

Erratum: Excretable IR-820 for in vivo NIR-II fluorescence cerebrovascular imaging and photothermal therapy of subcutaneous tumor: Erratum.

Adaptive Optics Fluorescence Lifetime Imaging Ophthalmoscopy of in Vivo Human Retinal Pigment Epithelium: Erratum

Erratum To: Targeting Apoptosis for Optical Imaging of Infection

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Correction To: Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells: the Effect of Combining RNA Interference with Tyrosine Kinase Inhibitors or Cetuximab

Erratum: Correction: Impaired Mitochondrial Energy Production Causes Light-Induced Photoreceptor Degeneration Independent of Oxidative Stress (PLoS biology (2015) 13 7 (e1002197))

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Erratum: A thermosensitive, reactive oxygen species-responsive, MR409-encapsulated hydrogel ameliorates disc degeneration in rats by inhibiting the secretory autophagy pathway: Erratum

Correction: Single Laser Activated Photothermal/photodynamic Dual-Modal Cancer Phototherapy by Using ROS-responsive Targeting Flower-Like Ruthenium Nanoparticles

Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy

Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy.

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches